EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Angong Niuhuang Wan ameliorates LPS-induced cerebrovascular edema by inhibiting blood‒brain barrier leakage and promoting the membrane expression of AQP4

Bo-Tong Liu, Quan Li, Kai Sun, Chun-Shui Pan, Xin-Mei Huo, Ping Huang, Li Yan, Qi-Hua He, Li-Jun Zhong, Yuan Wang, Meng-Lei Hu, An-Qing Li und 5 weitere

Frontiers in Pharmacology · 01.08.2024 · 15

DOI: 10.3389/fphar.2024.1421635 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Pharmacology, online erschienen am 01.08.2024. Verfasst von Bo-Tong Liu und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing, China. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Angong Niuhuang Wan (AGNHW), developed during the Qing dynasty (18th century) for the treatment of consciousness disturbances caused by severe infections, has been used to treat brain edema caused by ischemia‒reperfusion. However, it remains unclear whether AGNHW can ameliorate vascular-origin brain edema caused by lipopolysaccharides (LPS). This study explored the ameliorative effects of AGNHW on LPS-induced cerebrovascular edema in mice, as well as the potential underlying mechanisms.

Methods

A cerebrovascular edema model was established in male C57BL/6N mice by two intraperitoneal injections of LPS (15 mg/kg), at 0 and 24 h. AGNHW was administered by gavage at doses of 0.2275 g/kg, 0.455 g/kg, and 0.91 g/kg, 2 h after LPS administration. In control mice, normal saline (NS) or AGNHW (0.455 g/kg) was administered by gavage 2 h after intraperitoneal injection of NS. The survival rate, cerebral water content, cerebral venous FITC-dextran leakage, Evans blue extravasation, and expression of vascular endothelial cadherin (VE-cadherin), zonula occludens-1 (ZO-1), claudin-5, phosphorylated caveolin-1 (CAV-1), and cytomembrane and cytoplasmic aquaporin 1 (AQP1) and aquaporin 4 (AQP4) were evaluated. The cerebral tissue phosphoproteome, blood levels of AGNHW metabolites, and the relationships between these blood metabolites and differentially phosphorylated proteins were analyzed.

Results

AGNHW inhibited the LPS-induced decrease in survival rate, increase in cerebral water content, decrease in VE-Cadherin expression and increase in phosphorylated CAV-1 ( P -CAV-1). AGNHW treatment increased the expression of AQP4 on astrocyte membrane after LPS injection. AGNHW also inhibited the LPS-induced increases in the phosphorylation of 21 proteins, including protein kinase C-α (PKC-α) and mitogen-activated protein kinase 1 (MAPK1), in the cerebral tissue. Eleven AGNHW metabolites were detected in the blood. These metabolites might exert therapeutic effects by regulating PKC-α and MAPK1.

Conclusion

AGNHW can ameliorate cerebrovascular edema caused by LPS. This effect is associated with the inhibition of VE-Cadherin reduction and CAV-1 phosphorylation, as well as the upregulation of AQP4 expression on the astrocyte membrane, following LPS injection.

Schlagwörter

Stichwörter der Autor:innen

AQP4PKC-αVE-cadherinblood-brain barriercerebrovascular edema

Autor:innen und Institutionen

  • Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing, China.
  • Tasly Microcirculation Research Center, Peking University Health Science Center, Beijing, China.
  • The Key Discipline for Integration of Chinese and Western Basic Medicine (Microcirculation) of the National Administration of Traditional Chinese Medicine, Beijing, China.
  • Key Laboratory of Stasis and Phlegm, State Administration of Traditional Chinese Medicine of the People's Republic of China, Beijing, China.
  • Beijing Microvascular Institute of Integration of Chinese and Western Medicine, Beijing, China.
  • State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing, China.

Zitieren

APA

Liu, B. T., Li, Q., Sun, K., Pan, C. S., Huo, X. M., Huang, P., Yan, L., He, Q. H., Zhong, L. J., Wang, Y., Hu, M. L., Li, A. Q., Jiao, Y. Q., Zhang, S., Wang, X. Y., Liu, J., & Han, J. Y. (2024). Angong Niuhuang Wan ameliorates LPS-induced cerebrovascular edema by inhibiting blood‒brain barrier leakage and promoting the membrane expression of AQP4. Frontiers in Pharmacology, 15. https://doi.org/10.3389/fphar.2024.1421635

Vancouver

Liu BT, Li Q, Sun K, Pan CS, Huo XM, Huang P, et al. Angong Niuhuang Wan ameliorates LPS-induced cerebrovascular edema by inhibiting blood‒brain barrier leakage and promoting the membrane expression of AQP4. Frontiers in Pharmacology. 2024;15. doi:10.3389/fphar.2024.1421635

BibTeX
@article{Liu2024,
  author = {Liu, Bo-Tong and Li, Quan and Sun, Kai and Pan, Chun-Shui and Huo, Xin-Mei and Huang, Ping and Yan, Li and He, Qi-Hua and Zhong, Li-Jun and Wang, Yuan and Hu, Meng-Lei and Li, An-Qing and Jiao, Ying-Qian and Zhang, Shuang and Wang, Xiao-Yi and Liu, Jian and Han, Jing-Yan},
  title = {Angong Niuhuang Wan ameliorates LPS-induced cerebrovascular edema by inhibiting blood‒brain barrier leakage and promoting the membrane expression of AQP4},
  journal = {Frontiers in Pharmacology},
  year = {2024},
  volume = {15},
  doi = {10.3389/fphar.2024.1421635}
}
Kostenlos starten →